These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8883345)

  • 1. Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis.
    Jacobs AA; van den Berg AJ; Loeffen PL
    Vet Rec; 1996 Sep; 139(10):225-8. PubMed ID: 8883345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2.
    Lun S; Perez-Casal J; Connor W; Willson PJ
    Microb Pathog; 2003 Jan; 34(1):27-37. PubMed ID: 12620382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.
    Kock C; Beineke A; Seitz M; Ganter M; Waldmann KH; Valentin-Weigand P; Baums CG
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):135-45. PubMed ID: 19505730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and genetic diversity of suilysin in Streptococcus suis isolated from different diseases of pigs and characterization of the genetic basis of suilysin absence.
    King SJ; Heath PJ; Luque I; Tarradas C; Dowson CG; Whatmore AM
    Infect Immun; 2001 Dec; 69(12):7572-82. PubMed ID: 11705935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain.
    Busque P; Higgins R; Caya F; Quessy S
    Can J Vet Res; 1997 Oct; 61(4):275-9. PubMed ID: 9342451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2.
    Wisselink HJ; Stockhofe-Zurwieden N; Hilgers LA; Smith HE
    Vet Microbiol; 2002 Jan; 84(1-2):155-68. PubMed ID: 11731168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine.
    Wisselink HJ; Vecht U; Stockhofe-Zurwieden N; Smith HE
    Vet Rec; 2001 Apr; 148(15):473-7. PubMed ID: 11334073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of muraminidase-released protein (MRP), extracellular factor (EF) and suilysin by field isolates of Streptococcus suis capsular types 2, 1/2, 9, 7 and 3 isolated from swine in France.
    Berthelot-Hérault F; Morvan H; Kéribin AM; Gottschalk M; Kobisch M
    Vet Res; 2000; 31(5):473-9. PubMed ID: 11050742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization.
    Dekker CN; Bouma A; Daemen AJ; van Leengoed LA; Jonker FH; Wagenaar JA; Stegeman JA
    Vaccine; 2012 Feb; 30(7):1379-87. PubMed ID: 22210137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of suilysin, the thiol-activated haemolysin of Streptococcus suis, by field isolates from diseased pigs.
    Jacobs AA; van den Berg AJ; Baars JC; Nielsen B; Johannsen LW
    Vet Rec; 1995 Sep; 137(12):295-6. PubMed ID: 8533226
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological activities of suilysin: role in Streptococcus suis pathogenesis.
    Tenenbaum T; Asmat TM; Seitz M; Schroten H; Schwerk C
    Future Microbiol; 2016 Jul; 11():941-54. PubMed ID: 27357518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of recombinant bovine interleukin-1 beta and interleukin-2 in pigs vaccinated and challenged with Streptococcus suis.
    Blecha F; Reddy DN; Chitko-McKown CG; McVey DS; Chengappa MM; Goodband RD; Nelssen JL
    Vet Immunol Immunopathol; 1995 Feb; 44(3-4):329-46. PubMed ID: 7747410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to an autogenous vaccine and serologic profile for Streptococcus suis capsular type 1/2.
    Lapointe L; D'Allaire S; Lebrun A; Lacouture S; Gottschalk M
    Can J Vet Res; 2002 Jan; 66(1):8-14. PubMed ID: 11858652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9.
    Baums CG; Kock C; Beineke A; Bennecke K; Goethe R; Schröder C; Waldmann KH; Valentin-Weigand P
    Clin Vaccine Immunol; 2009 Feb; 16(2):200-8. PubMed ID: 19109449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of an avirulent strain that induces protective immunity against challenge with virulent Streptococcus suis serotype 2.
    Wang J; Feng Y; Wang C; Zheng F; Hassan B; Zhi L; Li W; Yao Y; He E; Jiang S; Tang J
    BMC Microbiol; 2017 Mar; 17(1):67. PubMed ID: 28292261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical situation, diagnosis and prevention of a Streptococcus suis serotype 7 problem on a farm].
    Unterweger C; Baums CG; Höcher M; Fischer L; Weiss A; Hennig-Pauka I
    Berl Munch Tierarztl Wochenschr; 2014; 127(5-6):194-201. PubMed ID: 24881269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of the Streptococcus suis suilysin gene and expression of MRP and EF correlates with high virulence in Streptococcus suis type 2 isolates.
    Staats JJ; Plattner BL; Stewart GC; Changappa MM
    Vet Microbiol; 1999 Dec; 70(3-4):201-11. PubMed ID: 10596804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence-associated gene profiling of Streptococcus suis isolates by PCR.
    Silva LM; Baums CG; Rehm T; Wisselink HJ; Goethe R; Valentin-Weigand P
    Vet Microbiol; 2006 Jun; 115(1-3):117-27. PubMed ID: 16431041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2.
    Seele J; Hillermann LM; Beineke A; Seitz M; von Pawel-Rammingen U; Valentin-Weigand P; Baums CG
    Vaccine; 2015 May; 33(19):2207-2212. PubMed ID: 25825330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative immunosecretome analysis of prevalent Streptococcus suis serotypes.
    Gómez-Gascón L; Luque I; Tarradas C; Olaya-Abril A; Astorga RJ; Huerta B; Rodríguez-Ortega MJ
    Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():55-61. PubMed ID: 30017079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.